Neuroblastoma trials in Canada

In Canada 13 Also abroad 128

13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2/3Taking people
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Where
Toronto
Age
18 months to 18 years
People
144 worldwide
Run by
Renaissance Pharma Ltd.
See details and how to joinNCT07549321 · EU 2025-524397-42-00
Early phase 1Taking people
Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation
Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
Age
Up to 6 years
People
15
Run by
C17 Council
See details and how to joinNCT06942039
Phase 3Taking people
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
Age
Up to 30 years
People
478 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06172296
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Calgary, Montreal, Toronto
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1/2Taking people
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Where
Montreal
Age
Up to 30 years
People
104 worldwide
Run by
Milton S. Hershey Medical Center
See details and how to joinNCT06541262
Phase 2Taking people
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Where
Calgary, Montreal, Québec, Sherbrooke
Age
Up to 22 years
People
500 worldwide
Run by
Giselle Sholler
See details and how to joinNCT02559778
Phase 3Taking people
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Where
Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, St. John's, Toronto, Vancouver, Winnipeg
Age
365 days to 30 years
People
750 worldwide
Run by
Children's Oncology Group
See details and how to joinNCT03126916
Phase 2Taking people
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Where
Montreal, Québec, Sherbrooke
Age
12 months to 21 years
People
93 worldwide
Run by
Giselle Sholler
See details and how to joinNCT05489887 · EU 2025-524140-35-00
Phase 2Taking people
68Ga-DOTATATE Neuroblastoma Imaging Pilot
Where
Montreal, Sherbrooke
Age
Up to 21 years
People
20
Run by
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
See details and how to joinNCT04559217
Phase 1/2Taking people
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Where
Montreal, Toronto, Vancouver
Age
12 months to 30 years
People
90 worldwide
Run by
St. Jude Children's Research Hospital
See details and how to joinNCT04901702
Phase 1Not yet taking people in Canada
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
Where
Montreal, Toronto
Age
2 years to 12 years
People
12
Run by
Michel Duval
See details and how to joinNCT07518654
No phaseTaking people
Neuroblastoma Biology Study
Where
Toronto
Age
31 days to 99 years
People
1,000 worldwide
Run by
New Approaches to Neuroblastoma Therapy Consortium
See details and how to joinNCT01587300
Phase 3Taking people
18F-DOPA II - PET Imaging Optimization
Where
Edmonton
People
800
Run by
University of Alberta
See details and how to joinNCT04706910